Leukemic Mantle Cell Lymphoma: Clinical and Pathologic Spectrum of Twenty-Three Cases

[1]  L. Medeiros,et al.  Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. , 2001, American journal of clinical pathology.

[2]  L. Medeiros,et al.  Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. , 2001, American journal of clinical pathology.

[3]  R. Gascoyne,et al.  Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma , 2000, Modern Pathology.

[4]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  F. Ajchenbaum‐Cymbalista,et al.  Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder , 1999, Leukemia.

[6]  J. So,et al.  Mantle cell lymphoma in leukemic phase , 1999, Cancer.

[7]  F. Bosch,et al.  Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma. , 1999, Cancer genetics and cytogenetics.

[8]  C. Ross,et al.  Leukemic phase of mantle cell lymphoma, blastoid variant. , 1999, American journal of clinical pathology.

[9]  F. Birg,et al.  Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. , 1999, Blood.

[10]  G. Salles,et al.  Mantle cell lymphoma: a retrospective study of 121 cases , 1998, Leukemia.

[11]  P. Cohen,et al.  Bone marrow and peripheral blood involvement in mantle cell lymphoma , 1998, British journal of haematology.

[12]  R. Gascoyne,et al.  Mantle cell lymphoma: a clinicopathologic study of 80 cases. , 1997, Blood.

[13]  W. Chan,et al.  p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. , 1996, Blood.

[14]  G. Inghirami,et al.  Large‐cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome , 1996, British journal of haematology.

[15]  F. Mitelman,et al.  Catalog of Chromosome Aberrations in Cancer , 1996, British Journal of Cancer.

[16]  S. Pittaluga,et al.  Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. , 1996, Leukemia & lymphoma.

[17]  C. Mecucci,et al.  Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. , 1995, Leukemia.

[18]  D C Louie,et al.  p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). , 1995, Blood.

[19]  N. Piva,et al.  Atypical chronic lymphocytic leukaemia witht(ll;14)(ql3;q32): karyotype evolution and prolymphocytic transformation , 1995, British journal of haematology.

[20]  T. Lister,et al.  Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[22]  M. Borowitz,et al.  Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. , 1993, American journal of clinical pathology.

[23]  K. Maclennan,et al.  Translocation t(11; 14)(q 13;q32) in chronic lymphoid disorders , 1992, Genes, chromosomes & cancer.

[24]  G. Gaidano,et al.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Jaffe,et al.  Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic and Immunophenotypic Spectrum and Clinical Correlations , 1990, The American journal of surgical pathology.

[26]  C. de Angeli,et al.  BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). , 2000, Haematologica.

[27]  A. Cuneo,et al.  Malignant Lymphomas BCL-1 rearrangements and p 53 mutations in atypical chronic lymphocytic leukemia with t ( 11 ; 14 ) ( q 13 ; q 32 ) , 2000 .

[28]  S. Pittaluga,et al.  Secondary chromosome changes in mantle cell lymphoma. , 1999, Haematologica.

[29]  C. Bloomfield,et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.